Literature DB >> 4691688

Effects of tracheostomy in two cases of hypersomnia with periodic breathing.

E Lugaresi, G Coccagna, M Mantovani, F Brignani.   

Abstract

Two non-obese patients suffering from hypersomnia with periodic breathing, who presented predominantly obstructive apnoea persisting throughout sleep, underwent tracheotomy with placement of a permanent tracheal cannula. Before tracheostomy there was a serious state of alveolar hypoventilation with a marked rise in pulmonary arterial pressure which appeared during sleep. After tracheostomy breathing during sleep became regular, pulmonary arterial pressure became normal, and daytime drowsiness disappeared. These observations suggest that the obstruction of the upper air tracts during sleep represents the most important factor in the pathogenesis of hypersomnia with periodic breathing.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4691688      PMCID: PMC494270          DOI: 10.1136/jnnp.36.1.15

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  The effects of natural sleep and hypersomnolent states on respiratory function.

Authors:  H O SIEKER; A HEYMAN; R I BIRCHFIELD
Journal:  Ann Intern Med       Date:  1960-03       Impact factor: 25.391

2.  Elevated end-tidal CO2 in trained underwater swimmers.

Authors:  L G GOFF; R G BARTLETT
Journal:  J Appl Physiol       Date:  1957-03       Impact factor: 3.531

3.  A peculiar type of cardiopulmonary failure associated with obesity.

Authors:  D CARROLL
Journal:  Am J Med       Date:  1956-11       Impact factor: 4.965

4.  Clinical and physiological aspects of a case of obesity, polycythemia and alveolar hypoventilation.

Authors:  J H AUCHINCLOSS; E COOK; A D RENZETTI
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808

5.  [Comparative sensitivity of the ascending activator reticular system and of the respiratory center to blood gas and to adrenalin].

Authors:  M BONVALLET; A HUGELIN; P DELL
Journal:  J Physiol (Paris)       Date:  1955

6.  [Effects of tracheotomy in hypersomnia with periodic respiration].

Authors:  E Lugaresi; G Coccagna; M Mantovani; F Brignani
Journal:  Rev Neurol (Paris)       Date:  1970-10       Impact factor: 2.607

7.  [Successful management of Pickwickian syndrome using long-term tracheostomy].

Authors:  W Kuhlo; E Doll; M C Franck
Journal:  Dtsch Med Wochenschr       Date:  1969-06-13       Impact factor: 0.628

8.  ["Ondine's curse": the disorder of respiration and sleep in primary alveolar hypoventilation].

Authors:  E Lugaresi; G Coccagna; G Berti Ceroni; A Petrella; M Mantovani
Journal:  Sist Nerv       Date:  1968 Jan-Feb

9.  [Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome].

Authors:  H Gastaut; C A Tassinari; B Duron
Journal:  Rev Neurol (Paris)       Date:  1965-06       Impact factor: 2.607

10.  [Comparative polygraphic study of the circadian cycle in narcoleptics, Pickwickians, the obese and patients with respiratory insufficiency].

Authors:  H Gastaut; B Duron; J J Papy; C A Tassinari; A Waltregny
Journal:  Rev Neurol (Paris)       Date:  1966-09       Impact factor: 2.607

View more
  4 in total

Review 1.  OSA and Cardiovascular Risk in Pediatrics.

Authors:  David F Smith; Raouf S Amin
Journal:  Chest       Date:  2019-02-18       Impact factor: 9.410

2.  Pickwickian syndrome, 20 years later.

Authors:  D Carroll
Journal:  Trans Am Clin Climatol Assoc       Date:  1975

Review 3.  Chronic intermittent hypoxia and hypertension: a review of systemic inflammation and Chinese medicine.

Authors:  Chun-Xiao Wu; Yue Liu; Jing-Chun Zhang
Journal:  Chin J Integr Med       Date:  2013-05-15       Impact factor: 1.978

Review 4.  OSAS and metabolic diseases: Round Table, 99(th) SIO National Congress, Bari 2012.

Authors:  D Passàli; P Tatti; M Toraldo; M de Benedetto; F Peverini; G Caruso; A Marzetti; F M Passàli; L Bellussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-06       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.